University of Cape Town
Rondebosch, Western Cape, South Africa
Purpose
to determine signatures of risk of tuberculosis (TB) disease, to ultimately be used for targeted therapy of persons subclinically infected with Mycobacterium tuberculosis (Mtb), and for enrollment of participants into trials of new TB vacci
Division
Global Health
Date
November 2012
Region Served
GLOBAL
Committed amount
$5,590,165
Grant topic
Tuberculosis
Duration (months)
80
Grantee location
Rondebosch, Western Cape, South Africa
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.